Orally administered erythromycin in rainbow trout (Oncorhynchus mykiss): Residues in edible tissues and withdrawal time

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 3, 2007, Pages 1043-1047

  Esposito, Annarita ^a   Fabrizi, Laura ^a   Lucchetti, Dario ^a   Marvasi, Luigi ^b   Coni, Ettore ^a   Guandalini, Emilio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; TRICAINE;

AQUACULTURE; AQUATIC SPECIES; ARTICLE; COST; ELECTROSPRAY MASS SPECTROMETRY; EUROPE; FEEDING; FISH DISEASE; ITALY; LIQUID CHROMATOGRAPHY; MUSCLE; NONHUMAN; OFF LABEL DRUG USE; PISCICULTURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAINBOW TROUT; WATER TEMPERATURE;

ANIMALS; ANTI-BACTERIAL AGENTS; DIET; DRUG RESIDUES; ERYTHROMYCIN; MEAT; MUSCLE, SKELETAL; ONCORHYNCHUS MYKISS; SKIN;

EID: 33847619275     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01002-06     Document Type: Article

References (37)

1. Akinbowale, O. L., H. Peng, and M. D. Barton. 2006. Antimicrobial resistance in bacteria isolated from aquaculture in Australia. J. Appl. Microbiol. 100:1103-1113.
2. Associazione Piscicoltori Italiani. 2005. La piscicoltura Italiana. Anno 2004. http://www.api-online.it.
3. Azevedo, P. A., J. Van Milgen, S. Leeson, and D. P. Bureau. 2005. Comparing efficiency of metabolizable energy utilization by rainbow trout (Oncorhynchus mykiss) and Atlantic salmon (Salmon salar) using factorial and multivariate approaches. J. Anim. Sci. 83:842-851.
4. Bailey, G. S., D. E. Williams, J. S. Wilcox, P. M. Loveland, R. A. Coulombe, and J. D. Hendricks. 1988. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish. Carcinogenesis 9:1919-1926.
5. Bandín, I., Y. Santos, A. E. Toranzo, and J. L. Barja. 1991. MICs and MBCs of chemotherapeutic agents against Renibacterium salmoninarum. Antimicrob. Agents Chemother. 35:1011-1013.
6. Burrows, G. E., D. D. Griffin, A. Pippin, and K. Harris. 1989. A comparison of the various routes of administration of erythromycin in cattle. J. Vet. Pharmacol. Ther. 12:289-295.
7. Commission decision (EEC) no. 657/2002. 2002. Commission decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (text with EEA relevance) (notified under document number C(2002) 3044). Official Journal of the European Communities L Ser. 221:8-36.
8. Costello, M. J., A. Grant, I. M. Davies, S. Cecchini, D. Papoutsoglou, D. Quigley, and M. Saroglia. 2001. The control of chemicals used in aquaculture in Europe. J. Appl. Ichthyol. 17(4):173-180.
9. Council Directive (EEC) no. 82/2001. 2001. Directive of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. Official Journal of the European Communities L Ser. 311:0001-0066.
10. Council Regulation (EEC) no. 2377/1990. 1990. Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal of the European Communities L Ser. 224:1-8.
11. Decreto legislativo n. 116 del 27/01/1992 (in Suppl. ordinario alla Gazz. Uff. n. 40, del 18 febbraio). 1992. Attuazione della direttiva (CEE) n. 609/86 in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici.
12. 14C]-erythromycin in the guinea pig. An autoradiographic study. Arzneimittelforschung. 37:524-527.
13. European Agency for the Evaluation of Medicinal Products. 1996. Note for guidance: approach towards harmonisation of withdrawal periods. EMEA, London, United Kingdom. http://www.emea.europa.eu/pdfs/vet/swp/003695en .pdf.
14. European Medicines Agency. 2006. Guideline on safety and residue data requirements for veterinary medicinal products intended for minor uses or minor species. EMEA, London, United Kingdom. http://www.emea.europa.eu /pdfs/vet/swp/6678105en.pdf.
15. Reference deleted.
16. Ewing, P. J., G. Burrows, C. MacAllister, and C. Clarke. 1994. Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles. J. Vet. Pharmacol. Ther. 17:17-23.
17. Fairgrieve, W. T., C. L. Masada, W. C. McAuley, M. E. Peterson, M. S. Myers, and M. S. Strom. 2005. Accumulation and clearance of orally administered erythromycin and its derivative, azithromycin, in juvenile fall chinook salmon Oncorhynchus tshawytscha. Dis. Aquat. Organ. 64:99-106.
18. Food and Agriculture Organization of the United Nations. 2005. Yearbooks of fishery statistics-2004. http://www.fao.org.
19. Ghittino, C., and M. Prearo. 1993. Comparison of some strains isolated from rainbow trout affected by streptococcosis. Boll. Soc. Ital. Patol. 11:30-43.
20. Kibwage, I. O., M. Michiels, R. Hendriks, T. Cachet, A. Verbrugger, J. Hoogmartens, and H. Vanderhaeghe. 1989. Tissue distribution and excretion of radioactively labelled compounds in the Wistar rat after administration of [N-methyl-14C]-erythromycin A. Eur. J. Drug Metab. Pharmacokinet. 14:7-14.
21. Krogdahl, A., A. Sundby, and J. J. Olli. 2004. Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss) digest and metabolize nutrients differently. Effects of water salinity and dietary starch level. Aquaculture 229:335-360.
22. Lakritz, J., W. D. Wilson, A. E. Marsh, and J. E. Mihalyi. 2000. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am. J. Vet. Res. 61:914-919.
23. Lucchetti, D., L. Fabrizi, A. Esposito, E. Guandalini, M. Di Pasquale, and E. Coni. 2005. Simple confirmatory method for the determination of erythromycin residues in trout: a fast liquid-liquid extraction followed by liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 53:9689-9694.
24. Lucchetti, D., L. Fabrizi, E. Guandalini, E. Podestà, L. Marvasi, A. Zaghini, and E. Coni. 2004. Long depletion time of enrofloxacin in rainbow trout (Oncorhynchus mykiss). Antimicrob. Agents Chemother. 48:3912-3917.
25. Lupin H. M., R. Subasinghe, and D. Alderman. 2003. Antibiotic residues in aquaculture products. In The state of world fisheries and aquaculture 2002. FAO, Rome, Italy.
26. Moffit, C. M., and J. A. Schreck. 1988. Accumulation and depletion of orally administered erythromycin thiocyanate in tissues of Chinook salmon. Trans. Am. Fish Soc. 117:394-400.
27. Moffitt, C. 1990. FDA approved registration of erythromycin for treatment of bacterial kidney disease in juvenile and adult chinook salmon. 1989-1990 annual report 1990, project no. 198903200. FDA, Washington, DC.
28. Moffitt, C. M., and Y. Kiryu. 2001. Acute and chronic toxicity following parenteral application of erythromycin (Erythro-200) to maturing spring Chinook salmon held at two water temperatures. J. Aquat. Anim. Health 13:8-19.
29. Moya, J., H. Pizarro, M. Jashes, E. De Clercq, and A. M. Sandino. 2000. In vivo effect of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole- carboxamide) on experimental infected rainbow trout (Oncorhynchus mykiss) and cohosalmon (Oncorhynchus kisutch) fry with infectious pancreatic necrosis virus. Antiviral Res. 48:125-130.
30. Petersen, A., J. S. Andersen, T. Kaewmak, T. Somsir, and A. Dalsgaard. 2002. Impact of integrated fish farming on antimicrobial resistance in a pond environment. Appl. Environ. Microbiol. 68:6036-6042.
31. Refstie, S., O. J. Korsoen, T. Storebakken, G. Baeverfjord, I. Lein, and A. J. Roem. 2000. Differing nutritional responses to dietary soybean meal in rainbow trout (Oncorhynchus mykiss) and Atlantic salmon (Salmo satar). Aquaculture 190:49-63.
32. Rohovec, J. S. 1991. Overview of selected diseases and drug needs for salmonids. Vet. Human Toxicol. 33:S24-S29.
33. Schmidtke, L. M., and J. Carson. 1999. Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. Vet. Microbiol. 69:287-300.
34. Schnick, R. A. 1991. An overview of current programs on drug development and regulation for aquaculture: U.S. Fish and Wildlife Service perspective. Vet. Human Toxicol. 33:S4-S5.
35. Shaikh, B., N. Rummel, C. Gieseker, S. Serfling, and R. Reimschuessel. 2003. Metabolism and residue depletion of albendazole and its metabolites in rainbow trout, tilapia and Atlantic salmon after oral administration. J. Vet. Pharmacol. Ther. 26:421-427.
36. Vanhaecke, E., P. De Backer, J. P. Remon, and L. A. Devriese. 1990. Pharmacokinetics and bioavailability of erythromycin in pigeons (Columba livia). J. Vet. Pharmacol. Ther. 13:356-360.
37. Yu, K. S., J. Y. Cho, J. H. Shon, K. S. Bae, S. Y. Yi, H. S. Lim, I. J. Jang, and S. G. Shin. 2001. Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin. Clin. Pharmacol. Ther. 70:228-236.